Eargo Past Earnings Performance
Past criteria checks 0/6
Eargo's earnings have been declining at an average annual rate of -35.8%, while the Medical Equipment industry saw earnings growing at 10.9% annually. Revenues have been declining at an average rate of 2.6% per year.
Key information
-35.8%
Earnings growth rate
83.6%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -2.6% |
| Return on equity | -239.7% |
| Net Margin | -263.1% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Eargo: Straining To Be Heard
Aug 30Eargo jumps 77% following FDA rule on OTC hearing aids
Aug 16Eargo Non-GAAP EPS of -$0.78 misses by $0.55, revenue of $7.25M misses by $21.05M
Aug 08Eargo completes $100M senior secured convertible notes issuance
Jul 05Eargo: A Binary Play On Hearing Loss
Dec 30Eargo Is A High Risk 'Option' With High Potential
Oct 08An Intrinsic Calculation For Eargo, Inc. (NASDAQ:EAR) Suggests It's 23% Undervalued
Jul 10
Eargo: I Am Slowly Starting To Listen
May 06What Kind Of Investors Own Most Of Eargo, Inc. (NASDAQ:EAR)?
Jan 16Eargo trades high afte hours on strong Q4 revenue, gross systems shipped
Jan 11Eargo: A Word Of Caution
Dec 15Eargo beats on revenue
Nov 19Revenue & Expenses BreakdownBeta
How Eargo makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 41 | -108 | 88 | 19 |
| 30 Jun 23 | 41 | -141 | 94 | 19 |
| 31 Mar 23 | 40 | -149 | 102 | 18 |
| 31 Dec 22 | 37 | -157 | 107 | 19 |
| 30 Sep 22 | 34 | -159 | 121 | 23 |
| 30 Jun 22 | 4 | -188 | 139 | 25 |
| 31 Mar 22 | 19 | -175 | 140 | 26 |
| 31 Dec 21 | 32 | -158 | 136 | 25 |
| 30 Sep 21 | 44 | -124 | 118 | 21 |
| 30 Jun 21 | 85 | -45 | 94 | 17 |
| 31 Mar 21 | 79 | -32 | 78 | 14 |
| 31 Dec 20 | 69 | -30 | 70 | 12 |
| 30 Sep 20 | 57 | -32 | 63 | 12 |
| 30 Jun 20 | 47 | -44 | 59 | 12 |
| 31 Mar 20 | 38 | -47 | 55 | 13 |
| 31 Dec 19 | 33 | -44 | 48 | 13 |
| 30 Sep 19 | 30 | -42 | 45 | 12 |
| 31 Dec 18 | 23 | -34 | 34 | 10 |
| 31 Dec 17 | 7 | -25 | 15 | 5 |
Quality Earnings: EAR is currently unprofitable.
Growing Profit Margin: EAR is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: EAR is unprofitable, and losses have increased over the past 5 years at a rate of 35.8% per year.
Accelerating Growth: Unable to compare EAR's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EAR is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.7%).
Return on Equity
High ROE: EAR has a negative Return on Equity (-239.7%), as it is currently unprofitable.